Hainan Huluwa Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 910.54 million compared to CNY 813.14 million a year ago. Revenue was CNY 910.54 million compared to CNY 813.14 million a year ago. Net income was CNY 77.36 million compared to CNY 75.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.2 a year ago.